Cadian Capital Management, LP Maxcyte, Inc. Transaction History
Cadian Capital Management, LP
- $1.95 Billion
- Q3 2024
A detailed history of Cadian Capital Management, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 8,188,948 shares of MXCT stock, worth $33.7 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
8,188,948
Previous 7,622,941
7.43%
Holding current value
$33.7 Million
Previous $29.9 Million
6.61%
% of portfolio
1.63%
Previous 1.49%
Shares
4 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Black Rock Inc. New York, NY8.14MShares$33.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$23.7 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$20.7 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.19MShares$17.2 Million0.01% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $418M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...